Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer.
Chang JY, Zhang W, Komaki R, Choi NC, Chan S, Gomez D, O'Reilly M, Jeter M, Gillin M, Zhu X, Zhang X, Mohan R, Swisher S, Hahn S, Cox JD.
Chang JY, et al.
Radiother Oncol. 2017 Feb;122(2):274-280. doi: 10.1016/j.radonc.2016.10.022. Epub 2017 Jan 28.
Radiother Oncol. 2017.
PMID: 28139305
Free PMC article.
Clinical Trial.
PURPOSE: The aim of this phase I/II study was to assess the long-term clinical benefits and toxicities of proton beam therapy for medically inoperable early-stage non-small cell lung cancer (NSCLC). ...Other grade 2 toxicities included esophagitis (2.9%), rib fracture (2.9 …
PURPOSE: The aim of this phase I/II study was to assess the long-term clinical benefits and toxicities of proton beam therapy for med …